Karyopharm Therapeutics (KPTI) EBITDA Margin Growth (5y) (2017 - 2026)
Karyopharm Therapeutics (KPTI) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14,964.00 |
| Dec 31, 2025 | 5,324.00 |
| Sep 30, 2025 | 18,627.00 |
| Jun 30, 2025 | 5,601.00 |
| Mar 31, 2025 | 15,029.00 |
| Dec 31, 2024 | 13,667.00 |
| Sep 30, 2024 | 23,188.00 |
| Jun 30, 2024 | 37,340.00 |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 2.78 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Jun 30, 2023 | 9,391.00 |
| Mar 31, 2023 | 30,957.00 |
| Dec 31, 2022 | 247,098.00 |
| Jun 30, 2022 | 99.16 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 5.35 Mn |
| Jun 30, 2021 | 5.14 Mn |
| Dec 31, 2020 | 11.71 Mn |